References:
1. Hoffman B, Amanullah A, Shafarenko M, Liebermann DA. 2002. The proto-oncogene c-myc in hematopoietic development and leukemogenesis. Oncogene 21(21): 3414-3421.
2. Boxer LM, Dang CV. 2001. Translocations involving c-myc and c-myc function. Oncogene 20(40):5595-5610.
3. Dang CV, Resar LM, Emison E, Kim S, Li Q, Prescott JE, Wonsey D, Zeller K. 1999. Function of the c-Myc oncogenic transcription factor. Exp Cell Res 253(1): 63-77.
4. Prendergast GC. 1999. Mechanisms of apoptosis by c-Myc. Oncogene 18(19):2967-2987.
5. Hillman MC, Yang LS, Sun S, Duke JL, O'Neil KT, Kochie JE, Karjoo A, Nath P, Breth LA, Murphy K, Ross OH, Burn TC, Hollis GF, Wynn R. 2001. A comprehensive system for protein purification and biochemical analysis based on antibodies to c-myc peptide. Protein Expr Purif. 23(2):359-68.
6. Xie LY, Abou-Samra AB. 1998. Epitope tag mapping of the extracellular and cytoplasmic domains of the rat parathyroid hormone (PTH)/PTH-related peptide receptor. Endocrinology. 139(11):4563-7.
7. Robertson D, Paterson HF, Adamson P, Hall A, Monaghan P. 1995. Ultrastructural localization of ras-related proteins using epitope-tagged plasmids. J Histochem Cytochem. 43(5):471-80.
8. Hilpert K, Hansen G, Wessner H, Kuttner G, Welfle K, Seifert M, Hohne W. 2001. Anti-c-myc antibody 9E10: epitope key positions and variability characterized using peptide spot synthesis on cellulose. Protein Eng. 14(10):803-6.